ClinicalTrials.Veeva

Menu

VTE Incidence in Severe Sepsis and Septic Shock

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Completed

Conditions

Severe Sepsis With Septic Shock

Treatments

Procedure: Ultrasound

Study type

Observational

Funder types

Other
NIH

Identifiers

Details and patient eligibility

About

Prospective studies on the incidence of VTE during severe sepsis and septic shock remain absent, hindering efficacy assessments regarding current VTE prevention strategies in septic patients. The investigators will prospectively study consecutively enrolled ICU patients with severe sepsis and septic shock admitted at three hospitals. All patients will provide informed consent and the study will be IRB approved. VTE thromboprophylaxis, provided per standard of care and according to the patients' primary team, will be recorded for all patients. Patients will undergo bilateral lower (and upper, if a central venous catheter [CVC] was present) comprehensive compression ultrasonography (CUS) and will be followed for symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) prior to discharge. The investigators will perform multivariate regression analyses to identify predictors of VTE.

Enrollment

113 patients

Sex

All

Ages

13+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ICU patients with severe sepsis and septic shock

Exclusion criteria

  • Admission diagnosis of acute VTE,
  • age < 13 years,
  • pregnancy,
  • severe chronic respiratory disease,
  • severe chronic liver disease (Child-Pugh Score of 11-15),
  • moribund patients not expected to survive 24 hours, and
  • acute myocardial infarction within 30 days.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems